宫颈癌的手术治疗:妇科肿瘤学会循证综述
本综述由妇科肿瘤学会组织专家组,围绕宫颈癌初始手术治疗提出12个临床问题,系统检索并整合文献,采用改良自ASCCP指南的两部分评级体系为每条推荐标注推荐强度与证据质量。推荐涵盖切除范围、保留生育功能手术、淋巴结评估、手术入路及手术与放化疗的整合。
要点
- 低危FIGO 2018 IA至IB1期疾病首选简单子宫切除术加淋巴结评估。
- 低危IA1至IB1期可考虑保留生育功能手术,锥切或简单子宫颈切除术优于根治性子宫颈切除术。
- 根治性子宫切除术适用时,临床试验之外首选开腹入路。
核心结论
- 各临床问题的证据质量差异较大,部分推荐基于观察性数据或专家共识。
研究设计与样本
- 妇科肿瘤学会循证综述,由妇科肿瘤学家与主题专家组成专家组确定12个临床问题,系统收集并整合相关文献,采用改良自ASCCP指南的两部分评级体系评定推荐强度与证据质量,推荐经SGO临床实践委员会、文件审查专家组及理事会批准。
主要发现
- 低危FIGO 2018 IA至IB1期疾病首选简单子宫切除术加淋巴结评估。
- 经适当选择的低危IA1至IB1期肿瘤患者可接受保留生育功能手术,锥切或简单子宫颈切除术优于根治性子宫颈切除术。
- 采用公认算法时,前哨淋巴结活检可替代完整盆腔淋巴结切除术,吲哚菁绿与近红外成像为首选示踪技术。
- 需行根治性子宫切除术时,临床试验之外首选开腹入路。
- 不推荐以新辅助化疗后手术替代放化疗,无残留病灶证据时不推荐在根治性放化疗完成后行子宫切除术。
关键数值与推荐
- 低危FIGO 2018 IA至IB1期:首选简单子宫切除术加淋巴结评估。
- 低危IA1至IB1期:保留生育功能手术可接受,锥切或简单子宫颈切除术优于根治性子宫颈切除术。
- 前哨淋巴结活检在采用公认算法时可替代完整盆腔淋巴结切除术,首选吲哚菁绿与近红外成像示踪。
- 根治性子宫切除术指征存在时,临床试验之外首选开腹入路。
- 不推荐新辅助化疗后手术替代放化疗;无残留病灶证据时不推荐放化疗后子宫切除术。
局限性
- 各临床问题的证据质量差异较大,部分推荐基于观察性数据或专家共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Surgical management of cervical cancer has changed substantially over the past decade as randomized and prospective data have refined the extent of resection, the role of fertility-sparing surgery, nodal assessment strategies, and the choice of surgical approach. This Society of Gynecologic Oncology evidence-based review addresses the upfront surgical management of cervical cancer. Surgery for recurrent disease, including pelvic exenteration and resection of oligometastatic recurrence, is outside its scope. A panel of gynecologic oncologists and subject matter experts identified twelve clinical questions spanning extent of resection, fertility-sparing surgery, lymph node assessment, surgical approach, and the integration of surgery with chemoradiation. Relevant literature was systematically collected and synthesized, and each recommendation was assigned a strength of recommendation and quality of evidence using a two-part rating system adapted from the ASCCP guidelines. Recommendations were approved by the SGO Clinical Practice Committee, Document Review Panel, and Board of Directors. Simple hysterectomy with nodal assessment is preferred for low-risk FIGO 2018 stage IA through IB1 disease. Fertility-sparing surgery is acceptable for appropriately selected patients with low-risk stage IA1 through IB1 tumors, with conization or simple trachelectomy preferred over radical trachelectomy. Sentinel lymph node biopsy may replace complete pelvic lymphadenectomy when an accepted algorithm is applied, with indocyanine green and near-infrared imaging the preferred mapping technique. When radical hysterectomy is indicated, the open approach is preferred outside of a clinical trial. Neoadjuvant chemotherapy followed by surgery is not recommended in place of chemoradiation, and hysterectomy after completion of definitive chemoradiation is not recommended in the absence of documented residual disease. Evidence quality varies considerably across questions, and several recommendations rest on observational data or expert consensus.
引用
- Melamed A, Covens AL, Pfaendler KS, et al. Surgical management of cervical cancer: A Society of Gynecologic Oncology evidence-based review. Gynecol Oncol. 2026. PMID: 43008586. doi:10.1016/j.ygyno.2026.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。